Ashok Kumar•Editor•![Amgen is hiring Associate Software Engineer [Freshers, Upto 12LPA Salary]](/_next/image?url=https%3A%2F%2Fbackend.talentd.in%2Fwp-content%2Fuploads%2F2025%2F02%2Famgen-1-1024x682.webp&w=3840&q=75)
Join Amgen’s dynamic team as an Associate Software Engineer and take part in transforming biological sciences into pioneering therapies. This role offers the chance to design, develop, and deploy complex software alongside leading professionals in the field. As an integral member of the team, you’ll contribute to creating scalable and maintainable solutions in a globally recognized biotechnology firm.
Proficiency in React, Redux, JavaScript, TypeScript, SQL, Microservices, AWS/Azure, and more. Experience with Agile methodologies and DevOps practices is preferred. Familiarity with API and End-to-End testing is beneficial.
This position welcomes graduates from recent batches, specifically 2023 and 2024
As a leader in biotechnology, Amgen prioritizes not just innovation but the welfare of its employees. The company offers competitive salaries and a comprehensive rewards program aligned with industry standards, promoting personal and professional growth. Be a part of their mission to improve lives—begin a career at Amgen today.
Amgen Inc. is one of the world’s largest independent biotechnology companies, founded in 1980 and headquartered in Thousand Oaks, California. Amgen’s mission is to serve patients by using science and innovation to dramatically improve people’s lives. The company focuses on discovering, developing, manufacturing, and delivering innovative human therapeutics, particularly in the areas of oncology, nephrology, cardiology, and inflammation.
With over 25,000 employees worldwide, Amgen is recognized for its robust pipeline and portfolio of biologic medicines, including well-known products such as Enbrel, Neulasta, and Repatha. The company is highly regarded for its commitment to scientific excellence and its leadership in biotechnology. In recent news, Amgen completed the acquisition of Horizon Therapeutics in 2023, significantly expanding its rare disease portfolio and reinforcing its position as a global biopharmaceutical leader.
Websiteamgen.com